NCT03565302

Beta2-adrenergic Agonism and Muscle Remodelling

Gender-specific Role of the beta2-adrenergic Stimulation With Short- or Long-acting Selective Agonist in Relation to Muscle Remodelling, Function, Performance, and Anti-doping

• Status: Unknown
• Phase: N/A
• Study type: Interventional
• Enrollment: 72 (estimated)
• Sponsor: Morten Hostrup, PhD · Academic / Other
• Sex: All
• Age: 18 Years – 45 Years
• Healthy volunteers: Accepted

Summary

The study aims to investigate gender-specific adaptations to beta2-adrenoceptor stimulation with selective short- and long-acting beta2-agonist with emphasis on skeletal muscle in relation to performance enhancing effects and anti-doping

Conditions

• Hypertrophy
• Physiologic Hypertrophy
• Physical Activity

Interventions

Type	Name	Description
DRUG	Formoterol	Subjects are treated with daily inhalation of formoterol
DRUG	Terbutaline	Subjects are treated with daily inhalation of terbutaline
OTHER	Placebo	Subjects are treated with placebo

Timeline

• Start date: 2018-06-25
• Primary completion: 2021-05-30
• Completion: 2021-05-30
• First posted: 2018-06-21
• Last updated: 2020-03-25

Locations

1 site across 1 country: Denmark